| John J Mara, MD | |
|
1111 Cromwell Ave Ste 404, Rocky Hill, CT 06067 | |
| (860) 525-4469 | |
| (860) 278-8803 |
| Full Name | John J Mara |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 46 Years |
| Location | 1111 Cromwell Ave Ste 404, Rocky Hill, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659335297 | NPI | - | NPPES |
| 01222801 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XS0106X | Orthopaedic Surgery - Hand Surgery | 022280 (Connecticut) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orthopedic Surgical Partners, P.c. | 1355394115 | 20 |
News Archive
In a new study by researchers at Yale Cancer Center, combining the immunotherapy drug durvalumab and PARP-inhibitor olaparib with chemotherapy improved response to treatment for women with high-risk, HER2-negative breast cancer, including a subset of estrogen receptor positive cancers.
Many people with painful, creaky knees and hips find relief after replacing their bad joints with new artificial joints made from titanium. But some of these people develop painful inflammation that can lead to bone destruction and loosening of the new joint. A new study led by researchers at the University of Medicine and Dentistry of New Jersey and published by the Journal of Immunology suggests that tiny titanium particles that flake away from the artificial joints through normal wear and tear may play a direct role in that inflammation.
The cholesterol drug alirocumab reduced low-density lipoprotein (LDL) cholesterol by 35.6% compared to placebo in adult patients with homozygous familial hypercholesterolemia (HoFH), according to a phase three clinical trial presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology.
Boehringer Ingelheim has announced that the September 15 issue of The Lancet will publish results from the RE-NOVATE study, which investigated dabigatran etexilate as a potential therapy for patients undergoing total hip replacement surgery.
Women who suffer from incontinence or pelvic organ prolapse from obesity, heavy lifting, smoking, chronic constipation or childbirth don't always need surgery according to a pioneering British medical device manufacturer.
› Verified 7 days ago
| Entity Name | Orthopedic Surgical Partners, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710017439 PECOS PAC ID: 1355394115 Enrollment ID: O20050222000478 |
News Archive
In a new study by researchers at Yale Cancer Center, combining the immunotherapy drug durvalumab and PARP-inhibitor olaparib with chemotherapy improved response to treatment for women with high-risk, HER2-negative breast cancer, including a subset of estrogen receptor positive cancers.
Many people with painful, creaky knees and hips find relief after replacing their bad joints with new artificial joints made from titanium. But some of these people develop painful inflammation that can lead to bone destruction and loosening of the new joint. A new study led by researchers at the University of Medicine and Dentistry of New Jersey and published by the Journal of Immunology suggests that tiny titanium particles that flake away from the artificial joints through normal wear and tear may play a direct role in that inflammation.
The cholesterol drug alirocumab reduced low-density lipoprotein (LDL) cholesterol by 35.6% compared to placebo in adult patients with homozygous familial hypercholesterolemia (HoFH), according to a phase three clinical trial presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology.
Boehringer Ingelheim has announced that the September 15 issue of The Lancet will publish results from the RE-NOVATE study, which investigated dabigatran etexilate as a potential therapy for patients undergoing total hip replacement surgery.
Women who suffer from incontinence or pelvic organ prolapse from obesity, heavy lifting, smoking, chronic constipation or childbirth don't always need surgery according to a pioneering British medical device manufacturer.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John J Mara, MD 1111 Cromwell Ave Ste 403, Rocky Hill, CT 06067-3454 Ph: (860) 525-4469 | John J Mara, MD 1111 Cromwell Ave Ste 404, Rocky Hill, CT 06067 Ph: (860) 525-4469 |
News Archive
In a new study by researchers at Yale Cancer Center, combining the immunotherapy drug durvalumab and PARP-inhibitor olaparib with chemotherapy improved response to treatment for women with high-risk, HER2-negative breast cancer, including a subset of estrogen receptor positive cancers.
Many people with painful, creaky knees and hips find relief after replacing their bad joints with new artificial joints made from titanium. But some of these people develop painful inflammation that can lead to bone destruction and loosening of the new joint. A new study led by researchers at the University of Medicine and Dentistry of New Jersey and published by the Journal of Immunology suggests that tiny titanium particles that flake away from the artificial joints through normal wear and tear may play a direct role in that inflammation.
The cholesterol drug alirocumab reduced low-density lipoprotein (LDL) cholesterol by 35.6% compared to placebo in adult patients with homozygous familial hypercholesterolemia (HoFH), according to a phase three clinical trial presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology.
Boehringer Ingelheim has announced that the September 15 issue of The Lancet will publish results from the RE-NOVATE study, which investigated dabigatran etexilate as a potential therapy for patients undergoing total hip replacement surgery.
Women who suffer from incontinence or pelvic organ prolapse from obesity, heavy lifting, smoking, chronic constipation or childbirth don't always need surgery according to a pioneering British medical device manufacturer.
› Verified 7 days ago
Michael Boniello, M.D., M.SC. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1111 Cromwell Ave Ste 404, Rocky Hill, CT 06067 Phone: 860-525-4469 | |
Robert W Mcallister, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1111 Cromwell Ave Ste 404, Rocky Hill, CT 06067 Phone: 860-525-4469 Fax: 860-278-8032 | |
Aris D. Yannopoulos, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1111 Cromwell Ave Ste 404, Rocky Hill, CT 06067 Phone: 860-525-4469 Fax: 860-278-8032 | |
Brian Schmidtberg, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1111 Cromwell Ave Ste 404, Rocky Hill, CT 06067 Phone: 860-525-4469 Fax: 860-278-8032 |